Mutational screening of six afibrinogenemic patients: Identification and characterization of four novel molecular defects

Luca Monaldini, Rosanna Asselta, Stefano Duga, Flora Peyvandi, Mehran Karimi, Massimo Malcovati, Maria Luisa Tenchini

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Congenital afibrinogenemia (CAF) is a rare coagulation disorder characterized by very low or unmeasurable levels of functional and immunoreactive fibrinogen in plasma, associated with a hemorrhagic phenotype of variable severity. It is transmitted as an autosomal recessive trait (prevalence 1: 1,000,000) and is invariantly associated with mutations affecting one of the three fibrinogen genes (FGA, FGB, and FGG, coding for Aα, Bβ, and γ chain, respectively). Fibrinogen is secreted by hepatocytes as a hexamer composed of two copies of each chain; the lack of one chain has been demonstrated to prevent its secretion. Most genetic defects causing afibrinogenemia are point mutations, whereas only three large deletions have been identified so far, all affecting the FGA gene. We here report the molecular characterization of six unrelated afibrinogenemic patients leading to the identification of eight different mutations, four hitherto unknown: a 4.1-Kb large deletion involving exon I of FGA (AC107385:g. 65682_69828del), two nonsense mutations (p.Trp229X in FGA and p.Trp266X in FGB), and an ins-del mutation (g. 1787_1789del3ins12) in FGA. The molecular characterization of CAF-causing genetic defects increases our understanding on the genetic basis of this disease and might be helpful for prenatal screening purposes, as also demonstrated during this study.

Original languageEnglish
Pages (from-to)546-551
Number of pages6
JournalThrombosis and Haemostasis
Volume97
Issue number4
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Afibrinogenemia
Fibrinogen
Mutation
Inborn Genetic Diseases
Nonsense Codon
Prenatal Diagnosis
Point Mutation
Genes
Hepatocytes
Exons
Phenotype

Keywords

  • Congenital afibrinogenemia
  • Fibrinogen
  • Large deletion
  • Mutational screening
  • Point mutations

ASJC Scopus subject areas

  • Hematology

Cite this

Mutational screening of six afibrinogenemic patients : Identification and characterization of four novel molecular defects. / Monaldini, Luca; Asselta, Rosanna; Duga, Stefano; Peyvandi, Flora; Karimi, Mehran; Malcovati, Massimo; Tenchini, Maria Luisa.

In: Thrombosis and Haemostasis, Vol. 97, No. 4, 04.2007, p. 546-551.

Research output: Contribution to journalArticle

@article{4ff99592138e4319b637b1b883d1292c,
title = "Mutational screening of six afibrinogenemic patients: Identification and characterization of four novel molecular defects",
abstract = "Congenital afibrinogenemia (CAF) is a rare coagulation disorder characterized by very low or unmeasurable levels of functional and immunoreactive fibrinogen in plasma, associated with a hemorrhagic phenotype of variable severity. It is transmitted as an autosomal recessive trait (prevalence 1: 1,000,000) and is invariantly associated with mutations affecting one of the three fibrinogen genes (FGA, FGB, and FGG, coding for Aα, Bβ, and γ chain, respectively). Fibrinogen is secreted by hepatocytes as a hexamer composed of two copies of each chain; the lack of one chain has been demonstrated to prevent its secretion. Most genetic defects causing afibrinogenemia are point mutations, whereas only three large deletions have been identified so far, all affecting the FGA gene. We here report the molecular characterization of six unrelated afibrinogenemic patients leading to the identification of eight different mutations, four hitherto unknown: a 4.1-Kb large deletion involving exon I of FGA (AC107385:g. 65682_69828del), two nonsense mutations (p.Trp229X in FGA and p.Trp266X in FGB), and an ins-del mutation (g. 1787_1789del3ins12) in FGA. The molecular characterization of CAF-causing genetic defects increases our understanding on the genetic basis of this disease and might be helpful for prenatal screening purposes, as also demonstrated during this study.",
keywords = "Congenital afibrinogenemia, Fibrinogen, Large deletion, Mutational screening, Point mutations",
author = "Luca Monaldini and Rosanna Asselta and Stefano Duga and Flora Peyvandi and Mehran Karimi and Massimo Malcovati and Tenchini, {Maria Luisa}",
year = "2007",
month = "4",
doi = "10.1160/TH06-12-0743",
language = "English",
volume = "97",
pages = "546--551",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - Mutational screening of six afibrinogenemic patients

T2 - Identification and characterization of four novel molecular defects

AU - Monaldini, Luca

AU - Asselta, Rosanna

AU - Duga, Stefano

AU - Peyvandi, Flora

AU - Karimi, Mehran

AU - Malcovati, Massimo

AU - Tenchini, Maria Luisa

PY - 2007/4

Y1 - 2007/4

N2 - Congenital afibrinogenemia (CAF) is a rare coagulation disorder characterized by very low or unmeasurable levels of functional and immunoreactive fibrinogen in plasma, associated with a hemorrhagic phenotype of variable severity. It is transmitted as an autosomal recessive trait (prevalence 1: 1,000,000) and is invariantly associated with mutations affecting one of the three fibrinogen genes (FGA, FGB, and FGG, coding for Aα, Bβ, and γ chain, respectively). Fibrinogen is secreted by hepatocytes as a hexamer composed of two copies of each chain; the lack of one chain has been demonstrated to prevent its secretion. Most genetic defects causing afibrinogenemia are point mutations, whereas only three large deletions have been identified so far, all affecting the FGA gene. We here report the molecular characterization of six unrelated afibrinogenemic patients leading to the identification of eight different mutations, four hitherto unknown: a 4.1-Kb large deletion involving exon I of FGA (AC107385:g. 65682_69828del), two nonsense mutations (p.Trp229X in FGA and p.Trp266X in FGB), and an ins-del mutation (g. 1787_1789del3ins12) in FGA. The molecular characterization of CAF-causing genetic defects increases our understanding on the genetic basis of this disease and might be helpful for prenatal screening purposes, as also demonstrated during this study.

AB - Congenital afibrinogenemia (CAF) is a rare coagulation disorder characterized by very low or unmeasurable levels of functional and immunoreactive fibrinogen in plasma, associated with a hemorrhagic phenotype of variable severity. It is transmitted as an autosomal recessive trait (prevalence 1: 1,000,000) and is invariantly associated with mutations affecting one of the three fibrinogen genes (FGA, FGB, and FGG, coding for Aα, Bβ, and γ chain, respectively). Fibrinogen is secreted by hepatocytes as a hexamer composed of two copies of each chain; the lack of one chain has been demonstrated to prevent its secretion. Most genetic defects causing afibrinogenemia are point mutations, whereas only three large deletions have been identified so far, all affecting the FGA gene. We here report the molecular characterization of six unrelated afibrinogenemic patients leading to the identification of eight different mutations, four hitherto unknown: a 4.1-Kb large deletion involving exon I of FGA (AC107385:g. 65682_69828del), two nonsense mutations (p.Trp229X in FGA and p.Trp266X in FGB), and an ins-del mutation (g. 1787_1789del3ins12) in FGA. The molecular characterization of CAF-causing genetic defects increases our understanding on the genetic basis of this disease and might be helpful for prenatal screening purposes, as also demonstrated during this study.

KW - Congenital afibrinogenemia

KW - Fibrinogen

KW - Large deletion

KW - Mutational screening

KW - Point mutations

UR - http://www.scopus.com/inward/record.url?scp=34247118412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247118412&partnerID=8YFLogxK

U2 - 10.1160/TH06-12-0743

DO - 10.1160/TH06-12-0743

M3 - Article

C2 - 17393016

AN - SCOPUS:34247118412

VL - 97

SP - 546

EP - 551

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -